HU900884D0 - Process for preparation of piperidine derivatives and producing of therapeutic compositions comprising the compounds - Google Patents

Process for preparation of piperidine derivatives and producing of therapeutic compositions comprising the compounds

Info

Publication number
HU900884D0
HU900884D0 HU90884A HU88490A HU900884D0 HU 900884 D0 HU900884 D0 HU 900884D0 HU 90884 A HU90884 A HU 90884A HU 88490 A HU88490 A HU 88490A HU 900884 D0 HU900884 D0 HU 900884D0
Authority
HU
Hungary
Prior art keywords
compounds
producing
preparation
therapeutic compositions
piperidine derivatives
Prior art date
Application number
HU90884A
Other languages
English (en)
Other versions
HU221623B1 (hu
HUT58326A (en
Inventor
Per Sauerberg
Preben Houlberg Olesen
Original Assignee
Ferrosan As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK82589A external-priority patent/DK82589A/da
Priority claimed from DK231589A external-priority patent/DK231589D0/da
Application filed by Ferrosan As filed Critical Ferrosan As
Publication of HU900884D0 publication Critical patent/HU900884D0/hu
Publication of HUT58326A publication Critical patent/HUT58326A/hu
Publication of HU221623B1 publication Critical patent/HU221623B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
HU9000884A 1989-02-22 1990-02-21 Eljárás piperidin-származékok és ilyen vegyületeket tartalmazó gyógyászati készítmények előállítására HU221623B1 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK82589A DK82589A (da) 1989-02-22 1989-02-22 Piperidinforbindelser, deres fremstilling og anvendelse
DK231589A DK231589D0 (da) 1989-05-12 1989-05-12 Piperidinforbindelser og deres fremstilling og anvendelse

Publications (3)

Publication Number Publication Date
HU900884D0 true HU900884D0 (en) 1990-05-28
HUT58326A HUT58326A (en) 1992-02-28
HU221623B1 HU221623B1 (hu) 2002-12-28

Family

ID=26064725

Family Applications (2)

Application Number Title Priority Date Filing Date
HU9000884A HU221623B1 (hu) 1989-02-22 1990-02-21 Eljárás piperidin-származékok és ilyen vegyületeket tartalmazó gyógyászati készítmények előállítására
HU95P/P00607P HU211705A9 (en) 1989-02-22 1995-06-29 Piperidine compounds, their preparation and use

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU95P/P00607P HU211705A9 (en) 1989-02-22 1995-06-29 Piperidine compounds, their preparation and use

Country Status (22)

Country Link
US (5) US5043345A (hu)
EP (2) EP0384288B1 (hu)
JP (2) JP2921578B2 (hu)
KR (1) KR0163763B1 (hu)
CN (1) CN1028105C (hu)
AR (1) AR247565A1 (hu)
AT (1) ATE123030T1 (hu)
AU (2) AU4999690A (hu)
CA (2) CA2010579A1 (hu)
DE (1) DE69019550T2 (hu)
DK (1) DK0384288T3 (hu)
ES (1) ES2072323T3 (hu)
FI (2) FI95704C (hu)
GR (1) GR3017062T3 (hu)
HU (2) HU221623B1 (hu)
IE (1) IE69672B1 (hu)
IL (2) IL93352A (hu)
NO (2) NO179639C (hu)
NZ (1) NZ232615A (hu)
PH (1) PH26465A (hu)
PT (2) PT93242A (hu)
RU (1) RU2042676C1 (hu)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0372125A1 (en) * 1988-11-08 1990-06-13 Akzo N.V. Oxazole and thiazole derivatives
US5264444A (en) * 1989-02-22 1993-11-23 Novo Nordisk A/S Piperidine compounds and use
US5260311A (en) * 1989-02-22 1993-11-09 Novo Nordisk A/S Piperidine compounds and their use
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
US5328925A (en) * 1989-02-22 1994-07-12 Novo Nordisk A/S Piperidine compounds and their use
EP0459568A3 (en) * 1990-05-31 1992-09-30 Merck Sharp & Dohme Ltd. Substituted oxadiazoles and thiadiazoles for use in the treatment of glaucoma and novel compounds having such use
US5527813A (en) * 1990-08-21 1996-06-18 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
DK198490D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
USRE35822E (en) * 1990-08-21 1998-06-09 Novo Nordisk A/S Heterocyclic compounds
US5418240A (en) * 1990-08-21 1995-05-23 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
DK198390D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
DK198590D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5376668A (en) * 1990-08-21 1994-12-27 Novo Nordisk A/S Heterocyclic compounds
AU656547B2 (en) * 1990-11-29 1995-02-09 Allergan, Inc. Use of pyridine derivatives in the treatment of ocular hypertension
EP0492903A1 (en) * 1990-12-21 1992-07-01 MERCK SHARP & DOHME LTD. Substituted pyrazines, pyrimidines and pyridazines for use in the treatment of glaucoma
IE922270A1 (en) * 1991-07-26 1993-01-27 Akzo Nv Pyrazole derivatives
US5641791A (en) * 1991-08-13 1997-06-24 Novo Nordisk A.S Heterocyclic compounds and their preparation and use
US5175166A (en) * 1991-08-27 1992-12-29 The University Of Toledo Muscarinic agonists
WO1993014089A1 (en) * 1992-01-13 1993-07-22 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
US5244906A (en) * 1992-01-23 1993-09-14 Dowelanco Insect control with substituted oxadiazole and thiadiazole compounds
US5631269A (en) * 1992-10-23 1997-05-20 Merck Sharp & Dohme Limited Dopamine receptor subtype ligands
AU698673B2 (en) * 1993-06-04 1998-11-05 Novo Nordisk A/S Heterocyclic chemistry
US5753683A (en) * 1993-08-19 1998-05-19 Novo Nordisk A/S Antipsychotic method
CZ285030B6 (cs) * 1993-08-19 1999-05-12 Novo Nordisk A/S Použití thiadiazolových a oxadiazolových sloučenin pro výrobu farmaceutického prostředku a farmacetický prostředek pro léčení schizofrenie nebo schizofrenních nemocí
IL112024A (en) * 1993-12-21 1999-07-14 Novo Nordisk As Pharmaceutical compositions comprising tetrahydropyridine derivatives substituted with oxadiazole or thiadiazole for treating gastrointestinal motility disorders
US5545638A (en) * 1993-12-21 1996-08-13 Novo Nordisk A/S Method of treating gastrointestinal motility disorders
US5672709A (en) * 1994-10-24 1997-09-30 Eli Lilly And Company Heterocyclic compounds and their preparation and use
US5605908A (en) * 1994-10-24 1997-02-25 Eli Lilly And Company Heterocyclic compounds and their use
US5998404A (en) * 1994-10-24 1999-12-07 Eli Lilly And Company Heterocyclic compounds and their use
US5726193A (en) * 1994-10-31 1998-03-10 Eli Lilly And Company Method for treating anxiety
US5484794A (en) * 1994-11-09 1996-01-16 Eli Lilly And Company Method for treating anxiety
ATE191344T1 (de) * 1994-10-31 2000-04-15 Lilly Co Eli Tetrahydropyridin oxadiazol- oder -thiadiazol- verbindung zur behandlung von angstzuständen
US5574028A (en) * 1994-10-31 1996-11-12 Eli Lilly And Company Method for treating anxiety
US5488056A (en) * 1994-10-31 1996-01-30 Eli Lilly And Company Method for treating anxiety
US5612351A (en) * 1994-11-08 1997-03-18 Novo Nordisk A/S Method of treating urinary bladder dysfunctions
US5565475A (en) * 1994-11-08 1996-10-15 Muhlhauser; Mark A. Method of treating urinary bladder dysfunctions with 3-tetrahydropyridine derivatives
TW304167B (hu) * 1995-01-30 1997-05-01 Lilly Co Eli
US5605701A (en) * 1995-02-17 1997-02-25 Eli Lilly And Company Transdermal formulation
US5763457A (en) 1995-11-13 1998-06-09 Eli Lilly And Company Method for treating anxiety
US5852037A (en) * 1995-11-13 1998-12-22 Eli Lilly And Company Method for treating anxiety
AU1128297A (en) * 1995-12-06 1997-06-27 Eli Lilly And Company Composition for treating pain
CA2239732A1 (en) * 1995-12-07 1997-06-12 Eli Lilly And Company Method for treating pain
GB9603755D0 (en) * 1996-02-22 1996-04-24 Pfizer Ltd Therapeutic agents
CA2250472A1 (en) * 1996-04-23 1997-10-30 Steven James Quimby Heterocyclic compounds
EP0912183A4 (en) * 1996-04-23 1999-08-04 Lilly Co Eli HETEROCYCLIC COMPOSITIONS
EP0910566B1 (en) * 1996-04-24 2003-09-17 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
US6090829A (en) * 1996-08-01 2000-07-18 Eli Lilly And Company Method for treating excessive aggression
EP0821956A1 (en) * 1996-08-01 1998-02-04 Eli Lilly And Company Method for treating disruptive behavior disorders
EP0821957A3 (en) * 1996-08-01 1998-04-22 Eli Lilly And Company Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (xanomeline) for treating substance abuse
EP0821954A1 (en) * 1996-08-01 1998-02-04 Eli Lilly And Company Method for treating mental retardation
US6043258A (en) * 1996-08-01 2000-03-28 Eli Lilly And Company Method for treating disruptive behavior disorders with xanomeline
EP0821958A3 (en) * 1996-08-01 1998-07-08 Eli Lilly And Company Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (xanomeline) for treating excessive aggression
ES2171838T3 (es) * 1996-08-01 2002-09-16 Lilly Co Eli Uso de 3-(4-hexiloxi-1,2,5-tiadiazol-3-il)-1,2,5,6-tetrahidro-1-metilpiridina (xanomelina) para el tratamiento del trastorno bipolar.
US6117890A (en) * 1996-08-01 2000-09-12 Eli Lilly And Company Method for treating bipolar disorder
EP0821959A3 (en) * 1996-08-01 1998-09-16 Eli Lilly And Company Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine for treating nicotine withdrawal
WO1998017214A1 (en) * 1996-10-23 1998-04-30 Eli Lilly And Company Method for treating dementia due to aids
AU7639598A (en) 1997-05-29 1998-12-30 H. Lundbeck A/S Treatment of schizophrenia and psychosis
US6034108A (en) * 1997-07-28 2000-03-07 Eli Lilly And Company Method for treating mental retardation
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
US6376675B2 (en) 1999-01-22 2002-04-23 The University Of Toledo Muscarinic receptor agonists
US6211204B1 (en) 1999-01-22 2001-04-03 University Of Toledo Muscarinic receptor agonists
US6096767A (en) * 1999-01-22 2000-08-01 The University Of Toledo Muscarinic receptor agonists
US20040023951A1 (en) * 2001-06-18 2004-02-05 Bymaster Franklin Porter Combination therapy for treatment of psychoses
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
CN1821243B (zh) * 2005-08-30 2010-12-08 北京大学 取代的吡啶类m1受体激动剂、其制备方法及其用途
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
EP1973904A2 (en) * 2005-12-27 2008-10-01 University Of Toledo Muscarinic agonists and methods of use thereof
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2026813A2 (en) 2006-05-09 2009-02-25 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2377531A2 (en) 2006-05-09 2011-10-19 Braincells, Inc. Neurogenesis by modulating angiotensin
US7998971B2 (en) 2006-09-08 2011-08-16 Braincells Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20110294835A1 (en) 2008-05-15 2011-12-01 The Board Of Trustees Of The University Of Illinois Muscarinic Agonists as Cognitive Enhancers
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
PL3061821T3 (pl) 2009-07-22 2020-01-31 PureTech Health LLC Kompozycje do leczenia zaburzeń łagodzonych przez aktywację receptora muskarynowego
US10265311B2 (en) 2009-07-22 2019-04-23 PureTech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
WO2012068161A1 (en) 2010-11-15 2012-05-24 Agenebio, Inc. Pyridazine derivatives, compositions and methods for treating cognitive impairment
WO2012149524A1 (en) 2011-04-29 2012-11-01 The University Of Toledo Muscarinic agonists as enhancers of working memory and cognitive flexibility
EP3083569B1 (en) 2013-12-20 2022-01-26 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
CN108026107B (zh) 2015-06-19 2021-07-30 艾吉因生物股份有限公司 用于治疗认知损害的苯并二氮杂环庚三烯衍生物、组合物和方法
WO2017044693A1 (en) 2015-09-11 2017-03-16 Chase Pharmaceuticals Corporation Muscarinic combination and its use for combating hypocholinergic disorders of the central nervous system
US20180170941A1 (en) 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
BR112019012821A2 (pt) 2016-12-19 2019-11-26 Agenebio Inc derivados de benzodiazepina, composições e métodos para o tratamento do comprometimento cognitivo
CA3104478A1 (en) 2018-06-19 2019-12-26 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
BR112021005802B1 (pt) 2018-09-28 2022-02-15 Karuna Therapeutics, Inc Composição farmacêutica oral
WO2021097427A1 (en) 2019-11-15 2021-05-20 Karuna Therapeutics, Inc. Xanomeline derivatives and methods for treating neurological disorders
WO2024039886A1 (en) 2022-08-19 2024-02-22 Agenebio, Inc. Benzazepine derivatives, compositions, and methods for treating cognitive impairment

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders
IL83275A (en) * 1986-09-08 1994-02-27 Novo Nordisk As Compounds 1,2, 4-Oxadiazolyl Pipridine Transformed, their preparation and pharmaceutical preparations containing them
US5017618A (en) * 1987-03-16 1991-05-21 University Of Florida Labile derivatives of ketone analogs of 3-substituted-1-alkylamino-2-propanols and their use as beta-adrenergic blockers
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
NZ225999A (en) * 1987-09-10 1992-04-28 Merck Sharp & Dohme Azacyclic- or azabicyclic-substituted thiadiazole derivatives and pharmaceutical compositions
IL88156A (en) * 1987-11-13 1997-02-18 Novo Nordisk As Azacyclic compounds their preparation and pharmaceutical compositions containing them
NZ227841A (en) * 1988-02-12 1991-08-27 Merck Sharp & Dohme Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions
DK162892C (da) * 1988-07-04 1992-05-11 Novo Nordisk As 1,2,5,6-tetrahydropyridinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende disse
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
US5328925A (en) * 1989-02-22 1994-07-12 Novo Nordisk A/S Piperidine compounds and their use
US5260311A (en) * 1989-02-22 1993-11-09 Novo Nordisk A/S Piperidine compounds and their use
US5264444A (en) * 1989-02-22 1993-11-23 Novo Nordisk A/S Piperidine compounds and use
DK198490D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
DK198390D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5175166A (en) * 1991-08-27 1992-12-29 The University Of Toledo Muscarinic agonists

Also Published As

Publication number Publication date
GR3017062T3 (en) 1995-11-30
RU2042676C1 (ru) 1995-08-27
CA2010578C (en) 2000-05-23
HU211705A9 (en) 1995-12-28
EP0384285A2 (en) 1990-08-29
NO900831D0 (no) 1990-02-21
PH26465A (en) 1992-07-27
NO179639C (no) 1996-11-20
PT93242A (pt) 1990-08-31
US5041455A (en) 1991-08-20
EP0384288A3 (en) 1991-04-10
EP0384288B1 (en) 1995-05-24
HU221623B1 (hu) 2002-12-28
AU4999790A (en) 1990-08-30
DE69019550D1 (de) 1995-06-29
JP2921578B2 (ja) 1999-07-19
FI900887A0 (fi) 1990-02-22
AU4999690A (en) 1990-08-30
CN1045104A (zh) 1990-09-05
PT93241B (pt) 1996-01-31
US5712297A (en) 1998-01-27
IE69672B1 (en) 1996-10-02
US5284859A (en) 1994-02-08
ES2072323T3 (es) 1995-07-16
IL93352A (en) 1994-08-26
EP0384285A3 (en) 1991-04-24
CN1028105C (zh) 1995-04-05
AU629302B2 (en) 1992-10-01
NO900830D0 (no) 1990-02-21
US5043345A (en) 1991-08-27
HUT58326A (en) 1992-02-28
JPH02255679A (ja) 1990-10-16
CA2010578A1 (en) 1990-08-22
PT93241A (pt) 1990-08-31
KR0163763B1 (ko) 1998-12-01
KR910015569A (ko) 1991-09-30
FI95704C (fi) 1996-03-11
IE900504L (en) 1990-08-22
NZ232615A (en) 1992-06-25
DK0384288T3 (da) 1995-10-02
IL93352A0 (en) 1990-11-29
DE69019550T2 (de) 1995-10-05
EP0384288A2 (en) 1990-08-29
FI95704B (fi) 1995-11-30
JPH02255680A (ja) 1990-10-16
FI900886A0 (fi) 1990-02-22
NO179639B (no) 1996-08-12
AR247565A1 (es) 1995-01-31
NO900830L (no) 1990-08-23
CA2010579A1 (en) 1990-08-22
IL93423A0 (en) 1990-11-29
NO900831L (no) 1990-08-23
US5559138A (en) 1996-09-24
ATE123030T1 (de) 1995-06-15

Similar Documents

Publication Publication Date Title
HU900884D0 (en) Process for preparation of piperidine derivatives and producing of therapeutic compositions comprising the compounds
HU896444D0 (en) Process for the preparation of pharmaceutical compositions
HUT50339A (en) Process for producing benzoxazole derivatives and pharmaceutical compositions comprising the compounds
HUT51613A (en) Process for producing piperidinyl-benzimidazole derivatives and pharmaceutical compositions containing these compounds
HUT53885A (en) Process for producing piridazinon derivatives of 2-hydroxy-n-propyl-amines and pharmaceutical compositions containing them
HUT59389A (en) Process for producing heterocyclic compounds and pharmaceutical compositions comprising same
HUT54139A (en) Process for producing n-heteroaryl-4-quinolineamine derivatives and pharmaceutical compositions comprising such compounds
HUT54112A (en) Process for producing benzocycloalkane derivatives and pharmaceutical compositions comprising same
HU896499D0 (en) Process for the preparation of piperidine derivatives
HUT48870A (en) Process for producing aminoalkoxyphenyl derivatives and pharmaceutical compositions comprising same
HUT48872A (en) Process for producing new dihydropyridine derivatives and pharmaceutical compositions comprising same
HUT49874A (en) Process for producing arylpiperazinylalkoxy derivatives of cyclic imides and pharmaceutical compositions comprising these compounds
HUT56342A (en) Process for producing capsoicin derivatives and pharmaceutical compositions comprising such compounds
HUT56078A (en) Process for producing piridazine derivatives and pharmaceutical compositions containing them
HU896612D0 (en) Process for the preparation of 2-iminebenzothiazole derivatives and pharmaceutical compositions thereof
HUT49871A (en) Process for producing indolylpiperidine derivatives and pharmaceutical compositions comprising same
HU904924D0 (en) Process for producing derivatives of human trombomoduline
HUT54146A (en) Process for producing new benzodioxole derivatives and pharmaceutical compositions comprising such compounds
HUT47119A (en) Process for producing 3-propenyl-cefem derivatives and pharmaceutical compositions comprising such compounds
HUT56373A (en) Process for producing pyranobenzoxadiazole derivatives and pharmaceutical compositions comprising such compounds
HUT48210A (en) Process for producing new tetrahydropyridine derivatives and pharmaceutical compositions comprising such compounds
HUT48867A (en) Process for producing new substituted styrene derivatives and pharmaceutical compositions comprising such compounds
HUT48591A (en) Process for producing new fluoromethoxyphenyl-dihydro-pyridines and pharmaceutical compositions comprising these compounds
HUT55758A (en) Process for producing pyridine derivatives and pharmaceutical compositions comprising such compounds
HUT53620A (en) Process for producing new thiouracyl derivatives and pharmaceutical compositions comprising same

Legal Events

Date Code Title Description
DGB9 Succession in title of applicant

Owner name: NOVO NORDISK A/S, DK

HMM4 Cancellation of final prot. due to non-payment of fee